Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes - Nature
- ️Baek, Sung Hee
- ️Thu Apr 14 2005
- Letter
- Published: 14 April 2005
- Bogyou Kim1 na1,
- Ling Cai2 na1,
- Hee June Choi1,
- Kenneth A. Ohgi2,
- Chris Tran3,
- Charlie Chen3,
- Chin Ha Chung1,
- Otmar Huber4,
- David W. Rose5,
- Charles L. Sawyers3,
- Michael G. Rosenfeld2 &
- …
- Sung Hee Baek1
Nature volume 434, pages 921–926 (2005)Cite this article
-
4372 Accesses
-
264 Citations
-
6 Altmetric
Abstract
Defining the molecular strategies that integrate diverse signalling pathways in the expression of specific gene programmes that are critical in homeostasis and disease remains a central issue in biology. This is particularly pertinent in cancer biology because downregulation of tumour metastasis suppressor genes is a common occurrence1,2, and the underlying molecular mechanisms are not well established. Here we report that the downregulation of a metastasis suppressor gene, KAI1, in prostate cancer cells involves the inhibitory actions of β-catenin, along with a reptin chromatin remodelling complex. This inhibitory function of β-catenin–reptin requires both increased β-catenin expression and recruitment of histone deacetylase activity. The coordinated actions of β-catenin–reptin components that mediate the repressive state serve to antagonize a Tip60 coactivator complex3,4,5,6,7,8 that is required for activation; the balance of these opposing complexes controls the expression of KAI1 and metastatic potential. The molecular mechanisms underlying the antagonistic regulation of β-catenin–reptin and the Tip60 coactivator complexes for the metastasis suppressor gene, KAI1, are likely to be prototypic of a selective downregulation strategy for many genes, including a subset of NF-κB target genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Change history
05 July 2022
A Correction to this paper has been published: https://doi.org/10.1038/s41586-022-04945-1
References
Shevde, L. A. & Welch, D. R. Metastasis suppressor pathways-an evolving paradigm. Cancer Lett.198, 1–20 (2003)
Steeg, P. S. Metastasis suppressors alter the signal transduction of cancer cell. Nature Rev. Cancer3, 55–63 (2002)
Feng, Y., Lee, N. & Fearon, E. R. Tip49 regulates β-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res.63, 8726–8734 (2003)
Bauer, A., Huber, O. & Kemler, R. Pontin52, an interaction partner of β-catenin binds to the TATA box binding protein. Proc. Natl Acad. Sci. USA95, 14787–14792 (1998)
Bauer, A. et al. Pontin52 and Reptin52 function as antagonistic regulators of β-catenin signaling activity. EMBO J.19, 6121–6130 (2000)
Wood, M. A., McMahon, S. B. & Cole, M. D. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol. Cell5, 321–330 (2000)
Rottbauer, W. et al. Reptin and pontin antagonistically regulate heart growth in zebrafish embryos. Cell111, 661–672 (2002)
Ikura, T. et al. Involvement of the Tip60 histone acetylase complex in DNA repair and apoptosis. Cell102, 463–473 (2000)
Petrylak, D. P. Metastases suppressors and prostate cancer. Nature Med.1, 739–740 (1995)
Dong, J.-T. et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science268, 884–886 (1995)
Dong, J.-T. et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res.56, 4387–4390 (1996)
Baek, S. H. et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell110, 55–67 (2002)
Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature411, 494–498 (2001)
Hannon, G. J. RNA interference. Nature418, 244–251 (2002)
Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J.16, 3797–3804 (1997)
Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M. & Byers, S. W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem.272, 24735–24738 (1997)
Cheshire, D. R. & Isaacs, W. B. β-Catenin signaling in prostate cancer: an early perspective. Endocr. Relat. Cancer10, 537–560 (2003)
Clever, H. Wnt breakers in colon cancer. Cancer Cell5, 5–6 (2004)
Moon, R. T., Bowerman, B., Boutros, M. & Perrimon, N. The promise and perils of Wnt signaling through β-catenin. Science296, 1644–1646 (2002)
Chesire, D. R., Ewing, C. M., Gage, W. R. & Isaacs, W. B. In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis. Oncogene21, 2679–2694 (2002)
Deng, J. et al. β-Catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell2, 323–334 (2002)
Li, J. et al. Novel NEMO/IκB kinase and NF-κB target genes at the pre-B to immature B cell transition. J. Biol. Chem.276, 18579–18590 (2001)
Albini, A. et al. A rapid in vitro assay for quantiating the invasive potential of tumor cells. Cancer Res.47, 3239–3245 (1987)
Kobayashi, H. et al. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathespin B. Cancer Res.52, 3610–3614 (1992)
Madrid, L. V. & Baldwin, A. S. Jr Regulation of NF-κB by oncoproteins and tumor suppressor protein. Methods Mol. Biol.223, 523–532 (2003)
Acknowledgements
We thank A. Hoffman for providing p50-knockout immortalized 3T3 cells; E. H. Koo and colleague for making KAI1-expressing LNCaP cells; D. A. Galloway for HPV-E6/E7 retroviral constructs; J.-T. Dong for KAI1 promoter clone; L. B. Owen-Schaub for Fas promoter reporter constructs; M.-C. Hung for mutant β-catenin constructs; K. Matsumoto for 293IL-RI cells; K. I. Kim, Y. K. Park and J. M. Lee for critical reading; and J. Hightower and M. Fisher for figure and manuscript preparation. We acknowledge support from the National R&D programme for cancer control from Ministry of Health & Welfare, Korea Research Foundation grant, and the BK21 Research Fellowship from the Ministry of Education and Human Resources Development (S.H.B.), the NIH (M.G.R., C.L.S., D.W.R.), and the Prostate Cancer Foundation (PCF) and the National Cancer Institute (NCI) (M.G.R.). M.G.R. is an HHMI Investigator.
Author information
Author notes
Jung Hwa Kim, Bogyou Kim and Ling Cai: These authors contributed equally to this work
Authors and Affiliations
Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, 151-742, South Korea
Jung Hwa Kim, Bogyou Kim, Hee June Choi, Chin Ha Chung & Sung Hee Baek
Department and School of Medicine, Howard Hughes Medical Institute, University of California, San Diego, La Jolla, California, 92093-0648, USA
Ling Cai, Kenneth A. Ohgi & Michael G. Rosenfeld
Howard Hughes Medical Institute, Department of Medicine, University of California, Los Angeles, Los Angeles, California, 90095, USA
Chris Tran, Charlie Chen & Charles L. Sawyers
Institute of Clinical Chemistry and Pathobiochemistry, Charite - Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany
Otmar Huber
Department of Medicine, Division of Endocrinology and Metabolism, School of Medicine, University of California, San Diego, San Diego, California, 92093, USA
David W. Rose
Authors
- Jung Hwa Kim
You can also search for this author inPubMed Google Scholar
- Bogyou Kim
You can also search for this author inPubMed Google Scholar
- Ling Cai
You can also search for this author inPubMed Google Scholar
- Hee June Choi
You can also search for this author inPubMed Google Scholar
- Kenneth A. Ohgi
You can also search for this author inPubMed Google Scholar
- Chris Tran
You can also search for this author inPubMed Google Scholar
- Charlie Chen
You can also search for this author inPubMed Google Scholar
- Chin Ha Chung
You can also search for this author inPubMed Google Scholar
- Otmar Huber
You can also search for this author inPubMed Google Scholar
- David W. Rose
You can also search for this author inPubMed Google Scholar
- Charles L. Sawyers
You can also search for this author inPubMed Google Scholar
- Michael G. Rosenfeld
You can also search for this author inPubMed Google Scholar
- Sung Hee Baek
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence to Michael G. Rosenfeld or Sung Hee Baek.
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests.
Supplementary information
Supplementary Figure S1
Primary tumour weights in prostate were comparable in both control vector-expressing and KAI1-expressing cell tumours. (GIF 24 kb)
Supplementary Figure S2
Tip60 was overexpressed in LNCaP cells and immunoblot assay confirmed the expression of Tip60. Validation of specific knock-down effects of Tip60 and pontin by specific shRNA was shown. (GIF 69 kb)
Supplementary Figure S3
A constitutive active mutant of β-catenin on Tip60 was overexpressed in RWPE1 cells or 293 cells and immunoblot confirmed the overexpression of β-catenin. Other target promoter activated by Tip60 in the presence of high levels of β-catenin was shown. Increase of β-catenin expression in the nucleus did not change the localization of Tip60. (GIF 234 kb)
Supplementary Figure S4
Histone deacetylase is crucial for the repressive function of reptin. Validation of function of shRNAs against β-catenin, reptin, HDAC1, or HDAC3 by immunoblot analysis was shown. Both GST-pulldown assay and in vivo immunoprecipitation assays revealed that the crucial region of reptin for binding to HDAC1. (GIF 322 kb)
Supplementary Figure S5
The PC-3 cells were used in Matrigel invasion assay. The PC-3 cells exhibited no reduction of invaded cells in response to IL-1β but increase of Tip60 expression exhibited an 80% decrease in Matrigel invasion compared to the non-treated control. (GIF 151 kb)
Supplementary Legend (DOC 24 kb)
Rights and permissions
About this article
Cite this article
Kim, J., Kim, B., Cai, L. et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434, 921–926 (2005). https://doi.org/10.1038/nature03452
Received: 13 December 2004
Accepted: 03 February 2005
Published: 14 April 2005
Issue Date: 14 April 2005
DOI: https://doi.org/10.1038/nature03452